BioSpace News Archive

Business

Orexo Interim Report Q1 2022

Christine Rankin and Michael J Matly were elected as Board members at the Annual General Meeting. They replace David Colpman and Kirsten Detrick who have declined re-election.

April 28, 2022
·
3 min read
Transcenta Announces First Patient Dosed in China Study of Anti-sclerostin Monoclonal Antibody TST002 for the Treatment of Osteoporosis

Transcenta Holding Limited announces the successful dosing of first patient in China Phase I Study of TST002 for the treatment of osteoporosis.

April 28, 2022
·
4 min read
Business

Sobi publishes Q1 2022 report

Swedish Orphan Biovitrum AB announced its report for the first quarter of 2022

April 28, 2022
·
3 min read
Business

MannKind Corporation to Hold 2022 First Quarter Financial Results Conference Call on May 5, 2022

MannKind Corporation will release its 2022 first quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM on Thursday, May 5, 2022.

April 28, 2022
·
1 min read
Business

West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend

West Pharmaceutical Services, Inc. announced its financial results for the first-quarter 2022 and updated full-year 2022 financial guidance.

April 28, 2022
·
12 min read
Policy

World’s First FDA Approved Cold Ablative Fiber Laser Makes US Debut

Acclaro Corporation, breaks new ground in medical devices for aesthetics with their revolutionary UltraClear™ system.

April 28, 2022
·
4 min read
Business

EVERSANA™ and Vector Pharma FZCO Announce Strategic Partnership to Expand Commercialisation Services Throughout Middle East and North Africa

EVERSANA™ and Vector Pharma FZCO of Dubai UAE announced a strategic partnership to expand services across the Middle East and North African markets.

April 28, 2022
·
3 min read
Genetown

Kelonia Therapeutics Launches with $50 Million Series A Financing to Pioneer Precision Targeted Genetic Medicines

Kelonia Therapeutics, a biotech company revolutionizing in vivo gene delivery, launched with a $50 million Series A financing to usher in a new era of genetic medicines for a wide range of diseases.

April 28, 2022
·
6 min read
Pharm Country

CytoSorbents Highlights the Strategy of “Enhanced Lung Rest” Using CytoSorb with ECMO to Help Treat Lung Failure at the 10th EuroELSO Congress

CytoSorbents Corporation announced that the Company will participate in the 10th EuroELSO Congress in London, UK being held May 4-6, 2022, one of the two major conferences for ECMO users worldwide.

April 28, 2022
·
9 min read
Policy

BeiGene Announces BRUKINSA (zanubrutinib) Approval in Uruguay in Mantle Cell Lymphoma, Marginal Zone Lymphoma, and Waldenström’s Macroglobulinemia

BeiGene announced that the BTK inhibitor BRUKINSA has been approved in Uruguay for the treatment of adult patients with previously treated mantle cell lymphoma, relapsed or refractory marginal zone lymphoma, and Waldenström’s macroglobulinemia.

April 28, 2022
·
11 min read